Maree T Smith

31PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMedical bacteriologyBiologically active moleculesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 10, 2026
An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

|Feb 16, 2026
Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants.

Viet Tin Pham, David M P De Oliveira, Andy Kuo

|Apr 11, 2025
Florasulam Is a Potent Inhibitor of Mycobacterium tuberculosis Acetohydroxyacid Synthase and Possesses In Vivo Antituberculosis Activity.

Shun Jie Wun, Lendl Tan, Thierry G Lonhienne

|Feb 20, 2025
The angiotensin II type 2 receptor antagonists, PD123,319 ((S-( +)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid), EMA300 (5-(2,2-diphenylacetyl)-4-[(4-methoxy-3-methylphenyl)methyl]-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-6-carboxylic acid) and EMA401 ((3S)-5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid), evoke pain relief in a varicella zoster virus-induced rat model of neuropathic pain.

V Das, A L Lam, M T Smith

|Dec 22, 2023
seco-1-Azacubane-2-carboxylic Acid: Derivative Scope and Comparative Biological Evaluation.

Dehui Kong, Tyler Fahrenhorst-Jones, Andy Kuo

|Apr 27, 2023
The NLRP3 inflammasome: role in the pathobiology of chronic pain.

Chen Chen, Maree T Smith

Pageof 6

Frequent Collaborators

16 joint publications

Andy Kuo

6 joint publications

Felicity Y Han

5 joint publications

Mohammad Zafar Imam

5 joint publications

Craig M Williams